1-deoxynojirimycin has been researched along with Pneumatosis Cystoides Intestinalis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aizawa, S; Fujii, H; Fukui, H; Kato, S; Kojima, K; Makutani, S; Mochi, T; Morimoto, T; Sawai, M; Tsujimoto, T; Yamamoto, K; Yasuhara, Y; Yoshioka, S | 1 |
1 review(s) available for 1-deoxynojirimycin and Pneumatosis Cystoides Intestinalis
Article | Year |
---|---|
Pneumatosis cystoides intestinalis induced by the α-glucosidase inhibitor miglitol.
Topics: 1-Deoxynojirimycin; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Male; Middle Aged; Pneumatosis Cystoides Intestinalis | 2010 |
1 other study(ies) available for 1-deoxynojirimycin and Pneumatosis Cystoides Intestinalis
Article | Year |
---|---|
Intestinal alpha-glucosidase inhibitors: abdominal gas cysts.
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Aged, 80 and over; alpha-Glucosidases; Enzyme Inhibitors; Female; Gases; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Intestinal Mucosa; Male; Middle Aged; Pneumatosis Cystoides Intestinalis; Predictive Value of Tests; Risk Assessment; Risk Factors | 2012 |